Cargando…
Chemokine Pathways in Cutaneous Melanoma: Their Modulation by Cancer and Exploitation by the Clinician
SIMPLE SUMMARY: Despite significant advances in immunotherapy seen in the last decade, melanoma accounts for 2500 deaths a year in the UK. There remains an unmet clinical need to improve melanoma treatment. Melanoma is known as the “archetypal immunogenic tumour”, with a dense immune infiltrate. Che...
Autores principales: | Adams, Rebecca, Moser, Bernhard, Karagiannis, Sophia N., Lacy, Katie E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615762/ https://www.ncbi.nlm.nih.gov/pubmed/34830780 http://dx.doi.org/10.3390/cancers13225625 |
Ejemplares similares
-
The Human Cutaneous Chemokine System
por: McCully, Michelle L., et al.
Publicado: (2011) -
Antibody therapies for melanoma: New and emerging opportunities to activate immunity (Review)
por: MALAS, SADEK, et al.
Publicado: (2014) -
B cells and the humoral response in melanoma: The overlooked players of the tumor microenvironment
por: Chiaruttini, Giulia, et al.
Publicado: (2017) -
IgG subclass switching and clonal expansion in cutaneous melanoma and normal skin
por: Saul, Louise, et al.
Publicado: (2016) -
B Lymphocytes Accumulate and Proliferate in Human Skin at Sites of Cutaneous Antigen Challenge
por: Egbuniwe, Isioma U., et al.
Publicado: (2022)